<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04352478</url>
  </required_header>
  <id_info>
    <org_study_id>13042020</org_study_id>
    <nct_id>NCT04352478</nct_id>
  </id_info>
  <brief_title>Incidental Cancer in Gallbladder Surgical Specimens Focus on Elderly Patients</brief_title>
  <official_title>Incidental Cancer in Gallbladder Surgical Specimens Focus on Elderly Patients, Retrospective Analysis of 2389 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Ersin Arslan Education and Training Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr. Ersin Arslan Education and Training Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Causes such as long-term stones and polyp are thought to play a role in the etiology of
      gallbladder cancer. The routine histopathological examination provides the detection of
      incidental gallbladder cancers. It should be remembered that acute or chronic cholecystitis
      accompanied by the thicked wall and a prolonged history of gallstones may be the cause of
      malignancy, especially in elderly patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aimed to incidental gallbladder cancer and compare other pathology results
      with elderly patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 20, 2020</start_date>
  <completion_date type="Actual">April 13, 2020</completion_date>
  <primary_completion_date type="Actual">April 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Incidental Cancer</measure>
    <time_frame>2 or 3 week</time_frame>
    <description>Number of Participants with adenocarcinom</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2389</enrollment>
  <condition>Pathology</condition>
  <arm_group>
    <arm_group_label>Elder</arm_group_label>
    <description>elderly (â‰¥60 years old).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young</arm_group_label>
    <description>young (&lt;60 years old)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Histopathological result</intervention_name>
    <description>Incidental gallbladder cancer and other pathology</description>
    <arm_group_label>Elder</arm_group_label>
    <arm_group_label>Young</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent cholecystectomy between January 2016 and February 2020 at our
        hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute cholecystectomy

          -  elective cholecystectomy

        Exclusion Criteria:

          -  lack of data

          -  incidental cholecystectomy,

          -  cholecystectomy secondary to trauma

          -  cholecystectomy secondary to malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ufuk Uylas</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Ersin Arslan Training and Resource Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Ersin Arslan Training and Resource Hospital</name>
      <address>
        <city>Gaziantep</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 13, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dr. Ersin Arslan Education and Training Hospital</investigator_affiliation>
    <investigator_full_name>Ufuk Uylas</investigator_full_name>
    <investigator_title>Specialist</investigator_title>
  </responsible_party>
  <keyword>cholecystectomy</keyword>
  <keyword>cholecystitis</keyword>
  <keyword>cholelithiasis</keyword>
  <keyword>gallbladder neoplasms</keyword>
  <keyword>histopathology</keyword>
  <keyword>surgical procedures</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

